We postulate that serum ApoL1 levels may elevate and exert certain biological activity in subjects with insulin resistance that frequently presents dyslipidemia marked by hypertriglyceridemia; however, the association between ApoL1 and insulin resistance has not been reported. The gene discussed is APOL1; the disease is metabolic syndrome.